ArticleBioactive materials2023

Reduction-responsive nucleic acid nanocarrier-mediated miR-22 inhibition of PI3K/AKT pathway for the treatment of patient-derived tumor xenograft osteosarcoma.

Dafu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.